Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing
about
Breastfeeding and Opiate Substitution Therapy: Starting to Understand Infant Feeding ChoicesABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and 2-Ethyl-5-methyl-3,3-diphenylpyroline (EMDDevelopment and validation of a method for the determination of buprenorphine and norbuprenorphine in breast milk by gas chromatography-mass spectrometry.ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman.Evaluation of the analgesic effect of subcutaneous methadone after cesarean section.Pharmacokinetics of methadone.Studying drugs in human milk: time to unify the approach.Feeding modalities and the onset of the neonatal abstinence syndrome.Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?Estimated infant exposure to enantiomer-specific methadone levels in breastmilkMethadone maintenance and lactation: a review of the literature and current management guidelines.Transfer of escitalopram and its metabolite demethylescitalopram into breastmilkDrug use and breastfeeding.Management of the newborn infant affected by maternal opiates and other drugs of dependency.Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.Bioanalytical procedures and recent developments in the determination of opiates/opioids in human biological samples.Maternal use of methadone and risk of sudden neonatal death.Maternal and neonatal hair and breast milk in the assessment of perinatal exposure to drugs of abuse.Pharmacological Management of Opioid Use Disorder in Pregnant Women.Promoting breastfeeding in an inner-city hospital: how to address the concerns of the maternity staff regarding illicit drug use.Forensic Investigation of Methadone Concentrations in Deceased Breastfed Infants.Is maternal opioid use hazardous to breast-fed infants?
P2860
Q26739956-D16A7D9F-8C2D-40B1-AEF7-B43149D0090DQ28081894-0D206163-28D1-47CA-813A-BAFDD97A13BAQ30490602-2DC7D735-75FA-4DE7-AFCC-4FC69C041287Q33437532-FC4A1E0E-334E-4CDF-A70E-0B1304B16E60Q33948169-7A6F767F-0200-47FC-B9A3-F3A5D13BF015Q34341036-FC3928F9-5CF3-4A52-BF10-ECF7BCA4E5A7Q34367724-3FFF67C9-91E0-48C6-A212-4C222DBD5D05Q34487284-BC248CC9-63B7-45F2-A7BB-55D970ED3FFBQ35007992-6E8A3189-7121-489C-AFA2-251E3F9DD227Q35124322-7757E854-DA59-4D47-BBCE-0042F7A1BB65Q35295236-5DF425F5-FF79-4C91-93AD-58C629E13F2DQ35586272-317B0436-7FF4-4BBD-A47E-AD7CF6A82E04Q35671539-A3999546-A577-4275-AFA2-0F5702CDDFCDQ35827773-F247AAEE-D27A-4F61-BAF6-CF8611A15FDDQ36191050-302E9762-72AB-4091-88B8-33B580AD333EQ36700962-54C8FC5D-D52B-4FF7-949A-040A43FB576CQ37761296-FA426241-D4F0-454B-920B-854AD510933EQ37858459-BE22B269-4D32-406F-9F6C-52ADAF69E160Q38502801-97D4353A-7F27-43FD-BC52-F13494A9DAA5Q38516618-77DD9A69-34C8-480C-A476-4D0597223B90Q38575591-2B4DECD6-86A3-42B4-8448-8632DE7EE2F3Q39669345-C38D3BB6-7343-4875-992B-8E7CA59D97B1Q40380339-4210547E-E08A-4067-A363-542FB73104D0Q43063862-0537B46C-4990-47DD-99FB-B2EE4E5DDB8F
P2860
Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Distribution of R- and S-metha ...... le, medium to high oral dosing
@ast
Distribution of R- and S-metha ...... le, medium to high oral dosing
@en
type
label
Distribution of R- and S-metha ...... le, medium to high oral dosing
@ast
Distribution of R- and S-metha ...... le, medium to high oral dosing
@en
prefLabel
Distribution of R- and S-metha ...... le, medium to high oral dosing
@ast
Distribution of R- and S-metha ...... le, medium to high oral dosing
@en
P2093
P2860
P1476
Distribution of R- and S-metha ...... le, medium to high oral dosing
@en
P2093
P2860
P304
P356
10.1046/J.0306-5251.2001.01506.X
P407
P577
2001-12-01T00:00:00Z